-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
10 of the State Drug Administration), after the demonstration and review organized by the State Drug Administration, the pain relief capsules were converted from prescription drugs to over-the-counter drugs
.
The list of varieties (Annex 1) and the model instructions for over-the-counter drugs (Annex 2) are published
together.
The holder of the marketing authorization for relevant drugs is requested to file the revised instructions with the provincial drug supervision and administration department in accordance with the relevant provisions of the Measures for the Administration of Drug Registration and other relevant provisions before June 15, 2023, and promptly notify the relevant medical institutions and drug trading enterprises of the revised content of the instructions
.
The contents of the instructions other than those specified in the model instructions for over-the-counter drugs shall be implemented
in accordance with the original approval documents.
Where drug labels involve relevant contents, they shall be revised
together.
Drugs produced from the date of filing shall not continue to use the original drug instructions
.
This is hereby announced
.
Attachments: 1.
List of varieties
serial number | name of article | Specifications (composition) | classify | remark |
1 | Pain Relief Capsules | 0. 3 g per capsule (equivalent to 1. 0 g of raw herbs) |
Class A |
Model instructions for over-the-counter drugs State Food and Drug Administration September 16, 2022